$Tempus AI (TEM.US)$ Tempus AI, Inc. (NASDAQ: TEM), a leader...
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that Medicare and Medicaid Service Centers (CMS) have granted Tempus advanced diagnostic clinical test (ADLT) status for next-generation sequencing.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
